Central nervous system mechanisms contributing to the cachexia-anorexia syndrome

scientific article

Central nervous system mechanisms contributing to the cachexia-anorexia syndrome is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/S0899-9007(00)00413-5
P698PubMed publication ID11054608

P2093author name stringPlata-Salamán CR
P2860cites workIn vivo IL-1beta-induced modulation of G-protein alphaO subunit subclass in the hypothalamic ventromedial nucleus: implications to IL-1beta-associated anorexiaQ28570397
Central nervous system control of food intakeQ29547439
Feeding and body-weight regulation by hypothalamic neuropeptides--mediation of the actions of leptinQ33544987
1998 Curt P. Richter Award. Brain mechanisms in cytokine-induced anorexiaQ33546758
Cytokine-cytokine interactions and the brainQ33827916
Regulation of hunger and satiety in man.Q36829816
Immunoregulators in the nervous systemQ37181575
Antisense oligodeoxynucleotides to G-protein alpha-subunit subclasses identify a transductional requirement for the modulation of normal feeding dependent on G alpha OA subunitQ38290728
Leptin treatment increases suppressors of cytokine signaling in central and peripheral tissuesQ38322266
Identification of SOCS-3 as a potential mediator of central leptin resistanceQ38335615
Interleukin-1beta (IL-1beta)-induced modulation of the hypothalamic IL-1beta system, tumor necrosis factor-alpha, and transforming growth factor-beta1 mRNAs in obese (fa/fa) and lean (Fa/Fa) Zucker rats: implications to IL-1beta feedback systems andQ40646423
Anorexia during acute and chronic diseaseQ41047136
Cancer cachexia: metabolic alterations and clinical manifestationsQ41371920
Tumors secreting human TNF/cachectin induce cachexia in miceQ44211776
Intracerebroventricular administration of a specific IL-1 receptor antagonist blocks food and water intake suppression induced by interleukin-1 betaQ44880489
Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary diseaseQ47366827
Meal patterns in response to the intracerebroventricular administration of interleukin-1 beta in ratsQ48142507
Hypothalamic concentration and release of neuropeptide Y into microdialysates is reduced in anorectic tumor-bearing ratsQ48200039
Interleukin-1 beta inhibits Ca2+ channel currents in hippocampal neurons through protein kinase C.Q48207522
Interleukin-1 beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus.Q48236899
Interleukin-1 (IL-1) receptor type I mediates anorexia but not adipsia induced by centrally administered IL-1betaQ48617484
In vivo regulation of the IL-1 beta system (ligand, receptors I and II, receptor accessory protein, and receptor antagonist) and TNF-alpha mRNAs in specific brain regionsQ48888055
Reduction in food and water intake induced by microinjection of interleukin-1 beta in the ventromedial hypothalamus of the rat.Q52213375
The Nutrition Implications of Cardiac CachexiaQ61663337
Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF alpha transgenic miceQ67540660
Anorexia induced by activators of the signal transducer gp 130Q71331319
Neuropeptide Y blocks and reverses interleukin-1 beta-induced anorexia in ratsQ71336170
Peripheral administration of interleukin-1 increases extracellular concentrations of norepinephrine in rat hypothalamus: comparison with plasma corticosteroneQ71460837
Leptin (OB protein), neuropeptide Y, and interleukin-1 interactions as interface mechanisms for the regulation of feeding in health and diseaseQ71818201
Correlation between food intake and CSF IL-1 alpha in anorectic tumor bearing ratsQ71860300
The cancer anorexia-cachexia syndromeQ72681492
Pathogenesis of cancer anorexia: personal perspectiveQ73127910
Anorexia during acute and chronic disease: relevance of neurotransmitter-peptide-cytokine interactionsQ73411604
Central nervous system IL-1 beta system and neuropeptide Y mRNAs during IL-1 beta-induced anorexia in ratsQ73764128
Neuropeptide Y counteracts interferon-alpha-induced anorexiaQ78209423
P433issue10
P921main subjectnervous systemQ9404
P304page(s)1009-1012
P577publication date2000-10-01
P1433published inNutritionQ15762858
P1476titleCentral nervous system mechanisms contributing to the cachexia-anorexia syndrome
P478volume16

Reverse relations

cites work (P2860)
Q34995229A difficult clinical problem: diagnosis, impact and clinical management of cachexia in palliative care
Q43701471Activity of body energy regulatory pathways in inflammation-induced anorexia.
Q35764044An infant with hyperalertness, hyperkinesis, and failure to thrive: a rare diencephalic syndrome due to hypothalamic anaplastic astrocytoma.
Q37780478Animal models of the cancer anorexia–cachexia syndrome
Q35140230Anorexia in cancer: role of feeding-regulatory peptides
Q88721761Appetite during the recovery phase of critical illness: a cohort study
Q34991293Are leptin and cytokines involved in body weight gain during treatment with antipsychotic drugs?
Q36635641CXCL12 sensitizes vago-vagal reflex neurons in the dorsal medulla
Q37633042CXCR4 receptors in the dorsal medulla: implications for autonomic dysfunction
Q24605567Cancer cachexia--pathophysiology and management
Q54785364Cancer incidence and mortality patterns in women with anorexia nervosa.
Q35214893Catabolic mediators as targets for cancer cachexia
Q47302575Critical weight loss in head and neck cancer--prevalence and risk factors at diagnosis: an explorative study
Q37781997Cytokine gene polymorphisms and susceptibility to cachexia
Q34011011Cytokines and cancer anorexia cachexia syndrome
Q38227496Cytokines: shifting the balance between glioma cells and tumor microenvironment after irradiation
Q34663975Effects of conditioned food aversions on nutritional behavior in humans
Q35946659Effects of intranasal administration of a leptin-secreting Lactococcus lactis recombinant on food intake, body weight, and immune response of mice.
Q47962128Effects of tumor necrosis factor α on leptin-sensitive intestinal vagal mechanoreceptors in the cat.
Q38311787Genetic basis of interindividual susceptibility to cancer cachexia: selection of potential candidate gene polymorphisms for association studies
Q34085744Ghrelin: an orexigenic and somatotrophic signal from the stomach
Q30437812How does immune challenge inhibit ingestion of palatable food? Evidence that systemic lipopolysaccharide treatment modulates key nodal points of feeding neurocircuitry
Q45912797Hyperlipidaemia in trypanosomiasis of naturally infected horses: possible cachexia-anorexia syndrome?
Q42910239Hypothalamic cocaine- and amphetamine-regulated transcript peptide is reduced and fails to modulate feeding behavior in rats with chemically-induced mammary carcinogenesis
Q37613162Hypothalamic inflammation and energy homeostasis: resolving the paradox
Q36550687Hypothalamic integration of immune function and metabolism
Q48912522Hypothalamus transcriptome profile suggests an anorexia-cachexia syndrome in the anx/anx mouse model
Q48388388Impaired voltage-gated K+ channel expression in brain during experimental cancer cachexia.
Q48459864Inducible-NOS but not neuronal-NOS participate in the acute effect of TNF-alpha on hypothalamic insulin-dependent inhibition of food intake
Q38555790Infertility with Testicular Cancer
Q92826626Inflammation, Appetite and Food Intake in Older Hospitalized Patients
Q28066646Inflammatory Cytokines and Antipsychotic-Induced Weight Gain: Review and Clinical Implications
Q35179104Influence of interleukin-6 and G174C polymorphism in IL-6 gene on obesity and energy balance
Q36464129Influence of proinflammatory cytokine gene polymorphism on childhood obesity
Q35893437Interleukin-6 and leptin as markers of energy metabolic changes in advanced ovarian cancer patients
Q37320958Intracerebroventricular urocortin 3 counteracts central acyl ghrelin-induced hyperphagic and gastroprokinetic effects via CRF receptor 2 in rats
Q43890306Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide
Q36309946Malnutrition and obesity in pediatric oncology patients: causes, consequences, and interventions
Q30275676Maternal systemic or cord blood inflammation is associated with birth anthropometry in a Tanzanian prospective cohort
Q42689447Meanings of eating deficiencies for people admitted to palliative home care
Q34764949Molecular-based therapeutic approaches in treatment of anorexia of aging and cancer cachexia
Q35001402Neural controls of prostaglandin 2 pyrogenic, tachycardic, and anorexic actions are anatomically distributed
Q34590839New drugs for the anorexia-cachexia syndrome
Q34565917Nutrition modulation of cachexia/proteolysis
Q37094850Paradoxical surrogate markers of dental injury-induced pain in the mouse
Q33723662Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer
Q37999707Possible involvement of brain-derived neurotrophic factor in eating disorders.
Q36052673Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents.
Q24657720Regulation of agouti-related protein messenger ribonucleic acid transcription and peptide secretion by acute and chronic inflammation
Q34669261Rikkunshito, a ghrelin potentiator, ameliorates anorexia-cachexia syndrome
Q48282089Role of cytokines in atypical depression
Q44833458Sex differences in severity of inflammation-induced anorexia and weight loss
Q55462089Successful treatment with a low-dose cisplatin--etoposide regimen for patients with diencephalic syndrome.
Q35006572TNF-alpha and adipocyte biology
Q33557318TRANSLATION OF BRAIN ACTIVITY INTO SLEEP.
Q36278394The cancer cachexia syndrome: a review of metabolic and clinical manifestations
Q38611320The embedded tumour: host physiology is important for the evaluation of tumour growth
Q96956054The impact of acute changes of inflammation on appetite and food intake among older hospitalized patients
Q36378758The origins of cachexia in acute and chronic inflammatory diseases.
Q79321014Thermal hyperalgesia and light touch allodynia after intradermal Mycobacterium butyricum administration in rat
Q55009518Tuberculosis, the Disrupted Immune-Endocrine Response and the Potential Thymic Repercussion As a Contributing Factor to Disease Physiopathology.
Q47662147Tumor necrosis factor alpha in sleep regulation
Q42445258Tumor necrosis factor alpha increases cytosolic calcium responses to AMPA and KCl in primary cultures of rat hippocampal neurons
Q48568200Tumor necrosis factor-alpha activates signal transduction in hypothalamus and modulates the expression of pro-inflammatory proteins and orexigenic/anorexigenic neurotransmitters